European Renal Association

Expanding therapeutic uses and regulatory concerns for GLP-1

36 clusters · 160 sources · last updated 1 day ago

Latest: Semaglutide treatments face high discontinuation rates

Medical research continues to expand the therapeutic potential of GLP-1 receptor agonists like semaglutide and tirzepatide. While semaglutide is widely used for weight loss and diabetes, new evidence suggests it may slow

European cardiovascular and kidney health guidelines

2 clusters · 4 sources · last updated 7 days ago

Latest: European guidelines link heart, kidney, and weight health

European medical experts have released updated clinical guidelines emphasizing the interconnectedness of cardiovascular disease, chronic kidney disease (CKD), and body weight. Initial guidance focused on the necessity